Clinical Trial Genotyping Services

Would you like information sent?
Simply complete the request form.

How to Order?
Click here

Web Seminar: Pharmacogenetics in the Practice of Medicine

Genelex has years of experience working with pharmaceutical companies and Contract Research Organizations to provide genotyping services for clinical trials or research studies. Advantages of working with Genelex include:

• GLP and CLIA compliant
• Dedicated customer support
• Rapid 2 day turnaround available
• Ability to test non-invasive buccal samples or blood
• Forensic-level protocols for sample accessioning

Genelex currently offers the following pharmacogenetic tests for research or clinical trials:

• Cytochrome P450 2D6 Genotyping
• Cytochrome P450 2C19 Genotyping
• Cytochrome P450 2C9 Genotyping
• Cytochrome P450 1A2 Genotyping
• N-Acetyltransferase 2 (NAT2) Genotyping
• Cytochrome P450 2C9 and VKORC1 Warfarin Genotyping

Here is what a visiting Quality Assurance Director had to say: "Everyone was very helpful, knowledgeable, and open with all of my requests.  The facility is neat and orderly and designed to prevent cross-contamination of samples (e.g., segregation during various sample preparation steps for PCR amplification).  The validation of the new technology was well planned and executed.  All of the requirements that I like to see were performed:

• On site training of all personnel by the Tag-It Kit manufacturer
• Parallel testing with an independent laboratory
• Testing of samples that challenge the system (Corriel Samples)
• Testing of normals (in-house blood draws)
• Duplicate testing of samples for correlation
• Development of positive controls for future testing (select Corriel Samples)
• Establishment of Proficiency Testing

All study and validation data correlated nicely and demonstrated an accurate, robust assay with a well-defined method of data interpretation."

For more information or to request a quote, please contact Kristine Ashcraft at kashcraft@genelex.com or 800-523-3080 x 2857.

By Kristine Ashcraft, B.S. Last Reviewed 8/20/10